share_log

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Why Baudax Bio Shares Are Trading Higher By 60%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

为什么 Baudax Bio 的股票交易价格上涨了 60%?以下是周二午盘时段其他股票的走势
Benzinga Real-time News ·  2023/01/24 13:12
Gainers
赢家
Baudax Bio, Inc. (NASDAQ:BXRX) shares surged 59.7% to $5.03 after the company announced the outcome of its first interim analysis in a Phase II trial of BX1000 for neuromuscular blockade in patients undergoing elective surgery. bioAffinity Technologies, Inc. (NASDAQ:BIAF) gained 46% to $2.34 after the company announed the publication of results of its clinical trial in peer-reviewed journal Respiratory Research. Axcella Health Inc. (NASDAQ:AXLA) shares jumped 36% to $0.59 after the company reported regulatory path to registration of AXA1125 for long COVID-19 fatigue. Grom Social Enterprises, Inc. (NASDAQ:GROM) gained 34.9% to $2.9950. Inhibikase Therapeutics, Inc. (NASDAQ:IKT) jumped 22.4% to $0.9190. Ontrak, Inc. (NASDAQ:OTRK) gained...
博达克斯生物公司纳斯达克(BXRX:BXX)股价飙升59.7%,至5.03美元,此前该公司宣布了BX1000第二阶段试验的第一个中期分析结果,该试验针对接受择期手术的患者使用神经肌肉阻滞。 生物亲...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发